NSC-23766

N/A

Report date: 2022/09/29 14:56:43
NME

Base Information

Drug NameNSC-23766
Drug Alias NameNSC-23766
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChildren's Hospital Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChildren's Hospital Research Foundation
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A